dalteparin and trelstar

dalteparin has been researched along with trelstar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ambrosini, G; Andrisani, A; Capobianco, G; Dessole, F; Marin, L; Vitagliano, A	1

Other Studies

1 other study(ies) available for dalteparin and trelstar

Article	Year
Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:4 Topics: Adult; Anticoagulants; Antineoplastic Agents, Hormonal; Ascites; Cryopreservation; Cryoprotective Agents; Drug Administration Schedule; Enoxaparin; Female; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Humans; Letrozole; Oocyte Retrieval; Oocytes; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Recombinant Proteins; Self Administration; Triple Negative Breast Neoplasms; Triptorelin Pamoate	2021

Article

Year

Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome.

Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:4

Topics: Adult; Anticoagulants; Antineoplastic Agents, Hormonal; Ascites; Cryopreservation; Cryoprotective Agents; Drug Administration Schedule; Enoxaparin; Female; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Humans; Letrozole; Oocyte Retrieval; Oocytes; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Recombinant Proteins; Self Administration; Triple Negative Breast Neoplasms; Triptorelin Pamoate

2021